| mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-05 |
| mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.18 |
8e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0002 |
| mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
-0.17 |
0.0002 |
| mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.098 |
0.001 |